SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001136261-18-000097
Filing Date
2018-04-09
Accepted
2018-04-09 16:20:16
Documents
3
Effectiveness Date
2018-04-09

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a.htm DEFA14A 4587
2 CARD image006.jpg GRAPHIC 106343
3 CARD image008.jpg GRAPHIC 105470
  Complete submission text file 0001136261-18-000097.txt   297642
Mailing Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960
Business Address 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 (862) 260-8457
PERNIX THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001024126 (see all company filings)

IRS No.: 330724736 | State of Incorp.: MD | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-14494 | Film No.: 18745782
SIC: 2834 Pharmaceutical Preparations